|
TXNDC16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01140000211097E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12349999806349E-08 |
| Normal-vs-Stage2 |
3.81920000003255E-06 |
| Normal-vs-Stage3 |
2.150900E-04 |
| Normal-vs-Stage4 |
7.628800E-04 |
| Stage1-vs-Stage2 |
9.442400E-01 |
| Stage1-vs-Stage3 |
3.006200E-01 |
| Stage1-vs-Stage4 |
9.890400E-01 |
| Stage2-vs-Stage3 |
3.878000E-01 |
| Stage2-vs-Stage4 |
9.526400E-01 |
| Stage3-vs-Stage4 |
5.618000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.87339998858738E-09 |
| Normal-vs-AfricanAmerican |
5.71719999999942E-05 |
| Normal-vs-Asian |
5.515200E-03 |
| Caucasian-vs-AfricanAmerican |
1.165380E-01 |
| Caucasian-vs-Asian |
8.586000E-01 |
| AfricanAmerican-vs-Asian |
7.130800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31400001990301E-10 |
| Normal-vs-Female |
1.884200E-03 |
| Male-vs-Female |
1.803080E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.94170000000771E-06 |
| Normal-vs-Extreme_Weight |
7.85090004118416E-09 |
| Normal-vs-Obese |
6.0543000000024E-05 |
| Normal-vs-Extreme_Obese |
1.78371999999261E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.162800E-01 |
| Normal_Weight-vs-Obese |
3.121000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.332400E-01 |
| Extreme_Weight-vs-Obese |
1.065630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.532800E-01 |
| Obese-vs-Extreme_Obese |
2.256200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.981200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.96259999996062E-06 |
| Normal-vs-Age(61-80Yrs) |
4.07409994629404E-10 |
| Normal-vs-Age(81-100Yrs) |
1.81160000001235E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.256600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.209590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.273900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.265840E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.069570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.888200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.24570000373348E-08 |
| Normal-VS-Type2 PRCC |
1.06900044372082E-11 |
| Normal-VS-KIRP CIMP |
8.626600E-01 |
| Normal-VS-Unclassified PRCC |
5.214700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.687900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.395640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.039600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.487500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.515700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.430800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.58755256005361E-12 |
| Normal-vs-N1 |
8.733700E-02 |
| Normal-vs-N2 |
2.009700E-02 |
| N0-vs-N1 |
3.826200E-02 |
| N0-vs-N2 |
5.999600E-01 |
| N1-vs-N2 |
5.258600E-01 |
|
|
